SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Paul A who wrote (2312)10/30/1998 9:07:00 PM
From: jopawa  Respond to of 4676
 
Paul,

I too used to own this stock, and made a little bit of money trading it. ISIP has a lot to offer and the risk/reward at this level seems very compelling to me in the LONG term. Short term I'm not sure, but who is? ISIP has gone from a long shot trading at 20, to a company with one drug approved (albeit small market), proven and unique science, tremendous potential with Crohn's, etc., trading at 9 with a market cap of 250 mil. I'll take my chances with 800 shares.

Good Luck

John



To: Paul A who wrote (2312)11/3/1998 9:32:00 PM
From: jopawa  Read Replies (2) | Respond to of 4676
 
Paul,

So, what did you do? No problems with the earnings, the selling last week was probably just some funds cleaning up their sheets at the end of their fiscal year. Stock still looks good here IMO.

John


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News